drugset / Trial / NCT03131726
Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
RandomizedParallel-groupSingle-blindTreatment
Summary
In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.
Timeline
- Start
- 2018-01-26
- Primary completion
- 2027-01-26
- Completion
- 2028-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 40 mg | — |